NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Research
Agency / Source: Veeda Clinical Research Ltd

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Veeda Oncology Announces New Service Line for Community-Based Oncology Practices - Veeda Oncology, a full service Oncology CRO with headquarters in Columbus, Ohio, has launched a valued new service line as part of its Site Management Services (SMO), Virtual Research Management (VRM), for community-based oncology practices
Veeda Oncology Announces New Service Line for Community-Based Oncology Practices

 

NewswireTODAY - /newswire/ - Ahmedabad, Gujarat, India, 2011/05/18 - Veeda Oncology, a full service Oncology CRO with headquarters in Columbus, Ohio, has launched a valued new service line as part of its Site Management Services (SMO), Virtual Research Management (VRM), for community-based oncology practices.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Virtual Research Management is a program that will provide management services to community-based oncology practices to enhance research program success. These services are individualized based on Veeda’s initial assessment of needs in collaboration with the practice preferences in areas such as strategic and financial planning, and operational support. By providing additional tools and resources, our services are meant to supplement current research programs in areas of existing need. This program has been successfully piloted at several community-based sites.

Sharon Jameson, BSN, MBA, Vice President, Clinical Development and Operations for the Veeda Oncology’s site management organization (SMO), stated,“Community based practices face many challenges in conducting oncology clinical trials in today’s economic environment. The primary challenges are meeting accrual goals while maintaining economic stability of the research program”.

“Veeda Oncology’s Research Management program has definitely elevated our ability to manage our research program both operationally and financially.” Administrator, NM practice

Veeda Oncology is a global Oncology CRO with operations in the US, Eastern/Western Europe and India. The company is a full service Oncology CRO for Phase I through Phase IV studies with the unique capability of providing rapid and strong global patient accrual with an effective cost structure.

Veeda Oncology (veedaoncology.com) is part of the Veeda Group (veedacr.com) that includes Veeda Clinical Research (Veeda CR), which is a leading CRO specializing in the early clinical development of drugs. With state of the art clinical pharmacology units in the UK, Europe and India, fully accredited GLP Laboratories and an established Biometrics team in Belgium and India, Veeda CR is able to offer clients a full range of Phase I-IIa services.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Veeda Clinical Research Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Veeda Oncology Announces New Service Line for Community-Based Oncology Practices

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Jilmil Joshi - VeedaCR.com 
jilmil.joshi[.]veedacr.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Veeda Clinical Research Ltd securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Veeda Clinical Research Ltd / Company Profile


Read Research Most Recent Related Newswires:

Motorola Solutions Announces New Global R&D Centre in Ireland
Naval Group Announces A New Collaboration Between Public and Private Research Studying the Electromagnetism of Ships
BASF Researching CO2-neutral Production of Bio-based Fumarate Using Bacteria Found in Cow Stomachs
SCHOTT Receives Over €1.3 Million to Advance Nuclear Fusion Research
NASA’s Jet Propulsion Laboratory Enhances Public Safety with CentralSquare Technologies’ Pro Suite
BASF to Research on Alternatives to Animal Testing on Behalf of the European Chemicals Agency (ECHA)
NEC Joins Columbia University-led National Science Foundation Engineering Research Center for Smart Streetscapes (CS3)
Tractebel to Conduct Feasibility Study for Iconic Einstein Telescope
Parexel Recognized with Frost & Sullivan’s 2023 North American Customer Value Leadership Award for Impactful Real-world Evidence Solutions
ABB and Imperial College Extend Carbon Capture Collaboration to Support Future Workforce and Energy Transition
ANDRITZ Opens The Food Innovation Xperience Test Center
Emulate Earns Frost & Sullivan’s 2023 Technology Innovation Leadership Award
CEA and Siemens Collaborate on Research to Expand Applications of Digital Twin for Industry
Innovative Research for Malaria Control Driven by Three Collaborating Parties - Swiss TPH, BASF and Promega
Aichi Cancer Center and NEC Develop an Efficient Method for Identifying Lung Cancer Antigens and Antigen-Specific T Cells

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  JobsWare.com





 
  ©2005-2024 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)